Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 253

1.

A 4-fold risk of metabolic syndrome in patients with schizophrenia: the Northern Finland 1966 Birth Cohort study.

Saari KM, Lindeman SM, Viilo KM, Isohanni MK, Järvelin MR, Laurén LH, Savolainen MJ, Koponen HJ.

J Clin Psychiatry. 2005 May;66(5):559-63.

PMID:
15889940
2.

Hyperlipidemia in persons using antipsychotic medication: a general population-based birth cohort study.

Saari K, Koponen H, Laitinen J, Jokelainen J, Lauren L, Isohanni M, Lindeman S.

J Clin Psychiatry. 2004 Apr;65(4):547-50.

PMID:
15119919
3.

Metabolic syndrome in patients with schizophrenia.

Heiskanen T, Niskanen L, Lyytikäinen R, Saarinen PI, Hintikka J.

J Clin Psychiatry. 2003 May;64(5):575-9.

PMID:
12755662
4.

High prevalence of the metabolic syndrome among a Swedish cohort of patients with schizophrenia.

Hägg S, Lindblom Y, Mjörndal T, Adolfsson R.

Int Clin Psychopharmacol. 2006 Mar;21(2):93-8.

PMID:
16421460
5.

Metabolic syndrome among persons with schizophrenia and other psychotic disorders in a general population survey.

Suvisaari JM, Saarni SI, Perälä J, Suvisaari JV, Härkänen T, Lönnqvist J, Reunanen A.

J Clin Psychiatry. 2007 Jul;68(7):1045-55.

PMID:
17685741
6.

Prevalence of the metabolic syndrome among patients receiving clozapine.

Lamberti JS, Olson D, Crilly JF, Olivares T, Williams GC, Tu X, Tang W, Wiener K, Dvorin S, Dietz MB.

Am J Psychiatry. 2006 Jul;163(7):1273-6.

PMID:
16816234
7.

The prevalence of metabolic syndrome among psychiatric inpatients in Brazil.

Teixeira PJ, Rocha FL.

Rev Bras Psiquiatr. 2007 Dec;29(4):330-6.

8.

Prevalence and predictors of metabolic syndrome among patients attending an outpatient clozapine clinic in Australia.

Brunero S, Lamont S, Fairbrother G.

Arch Psychiatr Nurs. 2009 Jun;23(3):261-8. doi: 10.1016/j.apnu.2008.06.007. Epub 2009 Jan 15.

PMID:
19446781
9.

Recovery from schizophrenic psychoses within the northern Finland 1966 Birth Cohort.

Lauronen E, Koskinen J, Veijola J, Miettunen J, Jones PB, Fenton WS, Isohanni M.

J Clin Psychiatry. 2005 Mar;66(3):375-83.

PMID:
15766305
10.

Metabolic syndrome and the risk of coronary heart disease in 367 patients treated with second-generation antipsychotic drugs.

Correll CU, Frederickson AM, Kane JM, Manu P.

J Clin Psychiatry. 2006 Apr;67(4):575-83.

PMID:
16669722
11.

Management of antipsychotic-induced weight gain: prospective naturalistic study of the effectiveness of a supervised exercise programme.

Poulin MJ, Chaput JP, Simard V, Vincent P, Bernier J, Gauthier Y, Lanctôt G, Saindon J, Vincent A, Gagnon S, Tremblay A.

Aust N Z J Psychiatry. 2007 Dec;41(12):980-9.

PMID:
17999270
12.

Prevalence of diabetes and the metabolic syndrome in a sample of patients with bipolar disorder.

van Winkel R, De Hert M, Van Eyck D, Hanssens L, Wampers M, Scheen A, Peuskens J.

Bipolar Disord. 2008 Mar;10(2):342-8. doi: 10.1111/j.1399-5618.2007.00520.x.

13.

Depressive symptoms predispose females to metabolic syndrome: a 7-year follow-up study.

Vanhala M, Jokelainen J, Keinänen-Kiukaanniemi S, Kumpusalo E, Koponen H.

Acta Psychiatr Scand. 2009 Feb;119(2):137-42. doi: 10.1111/j.1600-0447.2008.01283.x. Epub 2008 Nov 11.

PMID:
19016666
14.

Co-occurrence of metabolic syndrome with depression and anxiety in young adults: the Northern Finland 1966 Birth Cohort Study.

Herva A, Räsänen P, Miettunen J, Timonen M, Läksy K, Veijola J, Laitinen J, Ruokonen A, Joukamaa M.

Psychosom Med. 2006 Mar-Apr;68(2):213-6.

PMID:
16554385
15.

Metabolic syndrome in Italian patients with bipolar disorder.

Salvi V, Albert U, Chiarle A, Soreca I, Bogetto F, Maina G.

Gen Hosp Psychiatry. 2008 Jul-Aug;30(4):318-23. doi: 10.1016/j.genhosppsych.2008.04.009.

PMID:
18585534
16.

Metabolic syndrome and depression: a cross-sectional analysis.

Heiskanen TH, Niskanen LK, Hintikka JJ, Koivumaa-Honkanen HT, Honkalampi KM, Haatainen KM, Viinamäki HT.

J Clin Psychiatry. 2006 Sep;67(9):1422-7.

PMID:
17017829
17.

Prevalence of metabolic syndrome according to Adult Treatment Panel III and International Diabetes Federation criteria: a population-based study.

Bener A, Zirie M, Musallam M, Khader YS, Al-Hamaq AO.

Metab Syndr Relat Disord. 2009 Jun;7(3):221-9. doi: 10.1089/met.2008.0077.

PMID:
19320557
18.

Serum lipids in schizophrenia and other functional psychoses: a general population northern Finland 1966 birth cohort survey.

Saari K, Jokelainen J, Veijola J, Koponen H, Jones PB, Savolainen M, Järvelin MR, Lauren L, Isohanni M, Lindeman S.

Acta Psychiatr Scand. 2004 Oct;110(4):279-85.

PMID:
15352929
19.

Prevalence of the metabolic syndrome in veterans with schizophrenia.

Meyer J, Loh C, Leckband SG, Boyd JA, Wirshing WC, Pierre JM, Wirshing D.

J Psychiatr Pract. 2006 Jan;12(1):5-10.

PMID:
16432440
20.

School performance as a predictor of psychiatric hospitalization in adult life. A 28-year follow-up in the Northern Finland 1966 Birth Cohort.

Isohanni I, Järvelin MR, Nieminen P, Jones P, Rantakallio P, Jokelainen J, Isohanni M.

Psychol Med. 1998 Jul;28(4):967-74.

PMID:
9723151

Supplemental Content

Support Center